Lexaria Bioscience EPS Diluted from Tax Loss Carryforward (Quarterly) Insights

Lexaria Bioscience Corp. (LEXX)

0.7052 +0.03 (+4.47%) USD | NASDAQ | Mar 04, 16:00

0.7052 0.00 (0.00%) After-Hours: 20:00

View EPS Diluted from Tax Loss Carryforward (Quarterly) for LEXX.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View EPS Diluted from Tax Loss Carryforward (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View EPS Diluted from Tax Loss Carryforward (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View EPS Diluted from Tax Loss Carryforward (Quarterly) Benchmarks

Start Trial

Oncolytics Biotech, Inc.	--
Aurinia Pharmaceuticals, Inc.	--
Edesa Biotech, Inc.	--
Xenon Pharmaceuticals, Inc.	--
ProMIS Neurosciences, Inc.	--